• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTERVASCULAR SAS INTERGARD HEMABRIDGE WOVEN; VASCULAR POLYESTER GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTERVASCULAR SAS INTERGARD HEMABRIDGE WOVEN; VASCULAR POLYESTER GRAFT Back to Search Results
Model Number HEW3010BRIDGE
Device Problem Manufacturing, Packaging or Shipping Problem (2975)
Patient Problems Death (1802); Blood Loss (2597)
Event Date 04/21/2019
Event Type  Death  
Manufacturer Narrative
A review of the complaint device history records is ongoing, results are pending.The investigation is still ongoing.A follow-up report will be sent upon completion of the investigation.
 
Event Description
During a total arch replacement and tevar procedure, the surgeon connected the involved graft with a 3-branch hemashield graft, and the operation was completed.After angiostomy, bleeding was identified on the proximal part of the graft where a needle puncture was performed for deairing.At the completion of this first operation, small bleeding was observed but the surgeon thought it would stop and closed the patient's chest.However, the patient's condition was not good, and a second operation was performed.On the second exploration, bleeding occurred in the area where the two grafts were connected.Various hemostatic agents, like flosea and surgical berilast, were applied, which reduced the bleeding amount.About x20 pledgeted reinforcement interrupted sutures were placed on the blood oozing surface of the graft, and finally bleeding stopped.Blood transfusion and hemostatic pledget repair were performed for 2.5 hours.However, a few hours later, the patient had a heart arrest.Ecmo was performed but the patient died in a week (exact date of death is unknown).Additional information: transfusion : rbc 320cc 30ea, ffp 40cc 16ea.The patient had no bleeding tendency before the operation.
 
Manufacturer Narrative
Expiration has been corrected.(4117) device is not accessible for testing as it remained implanted in the patient.(3331/213) a review of the complaint device history records, indicated that the graft was processed and inspected according to established procedures and was therefore released following acceptable quality inspections and tests.Moreover, the review of the water permeability testing records of products coated on the same day as the complaint device indicated values well within product specifications (< 5 ml/cm²/min).(4109/213) the review of post-marketing historical data indicated that no other similar complaint was reported for the same lot number.(4315) no conclusion can be drawn since the product remained implanted.However, the conducted investigation suggests that the product was not defective at the time of manufacturing.The case has been reviewed by our corporate medical officer, his assessment is as follows: "it is difficult to speculate on the possible causes of the bleeding.It is however very uncommon for volume and area of interest.It could be assumed that due to the needle insertion and the subsequent closure the area surrounding the hole was subjected to additional stretch and trauma.Therefore, the collagen coating could have been disrupted causing the diffuse bleeding.However this remains speculation as in absence the specimen for analysis it is impossible to draw a conclusive assessment of the causes of the event.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERGARD HEMABRIDGE WOVEN
Type of Device
VASCULAR POLYESTER GRAFT
Manufacturer (Section D)
INTERVASCULAR SAS
z.i. athelia i
la ciotat cedex, 13705
FR  13705
MDR Report Key8649086
MDR Text Key146333632
Report Number1640201-2019-00030
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00384401001027
UDI-Public00384401001027
Combination Product (y/n)N
PMA/PMN Number
K013651
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Type of Report Initial,Followup
Report Date 07/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date05/31/2022
Device Model NumberHEW3010BRIDGE
Device Catalogue NumberHEW3010BRIDGE
Device Lot Number17F01
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/01/2019
Initial Date FDA Received05/29/2019
Supplement Dates Manufacturer Received06/07/2019
Supplement Dates FDA Received07/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age68 YR
Patient Weight63
-
-